This summary covers recent developments in health, including Novo Nordisk filing lawsuits against semaglutide compounders, bird flu affecting Brazilian chicken trade, and Novartis exploring a takeover of Avidity Biosciences. The US imposes tariffs on pharmaceutical imports, FDA approving Jazz Pharma’s new cancer drug, and concern over Gaza’s severe water crisis are also highlighted.
